Financhill
Back

Spyre Therapeutics Stock Predictions

Spyre Therapeutics Stock Forecast

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 5.4% based on the past 8 years of stock performance.
  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is Spyre Therapeutics Stock Undervalued?
    The current Spyre Therapeutics [SYRE] share price is $23.27. The Score for SYRE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Spyre Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 5.4% based on the past 8 years of stock performance.

Spyre Therapeutics Stock Rating

Sell
28
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics overpriced?

  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Spyre Therapeutics Stock Price History

Is SYRE stock going to rise?

  • The current trend is relatively stagnant and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com

52-Week Data

52-Week High:
47.97
52-Week Low:
20.07

Prediction Charts

Market Cap:
1.4B
Price in USD:
23.27
Volume:
467.8K
Beta:
2.48

Technical Analysis

SMA50:
23.66
SMA100:
27.41
SMA200:
28.69
52-Wk Change:
3.24%

Stock Predictions

  • Is Spyre Therapeutics stock public?
    Yes, Spyre Therapeutics is a publicly traded company.
  • What is the Spyre Therapeutics stock quote today?
    The Spyre Therapeutics stock price is 23.27 USD today.
  • How to buy Spyre Therapeutics stock online?
    You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-24 21.85 21.60 22.44 21.00
Jan-27 21.31 20.82 22.81 20.66
Jan-28 20.77 21.79 22.00 20.25
Jan-29 21.66 21.90 22.18 21.35
Jan-30 22.13 22.27 22.74 21.79
Jan-31 22.50 22.99 23.59 22.25
Feb-3 22.04 22.90 23.68 21.67
Feb-4 22.75 23.70 23.84 22.60
Feb-5 23.78 23.56 24.83 23.41
Feb-6 23.54 23.86 24.35 23.42
Feb-7 23.72 22.65 24.39 22.44
Feb-10 22.87 22.75 23.00 22.11
Feb-11 22.35 22.15 22.75 21.90
Feb-12 21.63 23.27 23.35 21.13

Spyre Therapeutics Earnings

Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Spyre Therapeutics Forecast Revenue Growth

Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $1.17 per share.

* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.